{"title":"Improving Inpatient COVID-19 Vaccination Rates Among Adult Patients at a Tertiary Academic Medical Center","authors":"Guzmán","doi":"10.12788/jcom.0108","DOIUrl":null,"url":null,"abstract":"Objective: Inpatient vaccination initiatives are well described in the literature. During the COVID-19 pandemic, hospitals began administering COVID-19 vaccines to hospitalized patients. Although vaccination rates increased, there remained many unvaccinated patients despite community efforts. This quality improvement project aimed to increase the COVID-19 vaccination rates of hospitalized patients on the medicine service at the George Washington University Hospital (GWUH). Method(s): From November 2021 through February 2022, we conducted a Plan-Do-Study-Act (PDSA) cycle with 3 phases. Initial steps included gathering baseline data from the electronic health record and consulting stakeholders. The first 2 phases focused on educating housestaff on the availability, ordering process, and administration of the Pfizer vaccine. The third phase consisted of developing educational pamphlets for patients to be included in their admission packets. Result(s): The baseline mean COVID-19 vaccination rate (August to October 2021) of eligible patients on the medicine service was 10.7%. In the months after we implemented the PDSA cycle (November 2021 to February 2022), the mean vaccination rate increased to 15.4%. Conclusion(s): This quality improvement project implemented measures to increase administration of the Pfizer vaccine to eligible patients admitted to the medicine service at GWUH. The mean vaccination rate increased from 10.7% in the 3 months prior to implementation to 15.4% during the 4 months post implementation. Other measures to consider in the future include increasing the availability of other COVID-19 vaccines at our hospital and incorporating the vaccine into the admission order set to help facilitate vaccination early in the hospital course. Copyright © 2022 Turner White Communications Inc.. All rights reserved.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Outcomes Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/jcom.0108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
提高高等院校医疗中心成年患者新冠肺炎住院疫苗接种率
目的:住院患者的疫苗接种计划在文献中有很好的描述。在新冠肺炎大流行期间,医院开始为住院患者接种新冠肺炎疫苗。尽管疫苗接种率有所提高,但尽管社区做出了努力,仍有许多患者未接种疫苗。该质量改进项目旨在提高乔治华盛顿大学医院(GWUH)医疗服务住院患者的新冠肺炎疫苗接种率。方法:从2021年11月到2022年2月,我们进行了一个分为3个阶段的计划-实践-研究法案(PDSA)周期。最初的步骤包括从电子健康记录中收集基线数据,并咨询利益攸关方。前两个阶段的重点是教育家庭工作人员辉瑞疫苗的可用性、订购过程和管理。第三阶段包括为患者编写教育小册子,将其纳入入院包中。结果:符合条件的医疗服务患者的基线平均新冠肺炎疫苗接种率(2021年8月至10月)为10.7%。在我们实施PDSA周期后的几个月内(2021年11月至2022年2月),平均疫苗接种率提高到15.4%。结论:该质量改进项目实施了一些措施,以增加GWUH医疗服务中合格患者的辉瑞疫苗接种量。平均疫苗接种率从实施前3个月的10.7%增加到实施后4个月的15.4%。未来需要考虑的其他措施包括增加我院其他新冠肺炎疫苗的供应量,并将疫苗纳入入院令,以帮助在住院早期接种疫苗。版权所有©2022 Turner White Communications股份有限公司。保留所有权利。
本文章由计算机程序翻译,如有差异,请以英文原文为准。